MLchartDataset catalogue

Droxia

Term · Oncology and biomedicine · MLC-T-ONC-002587

A drug that contains the active ingredient hydroxyurea and is used to treat certain patients with sickle cell anemia. It is also being studied in the treatment of other conditions and some types of cancer. Droxia may help keep abnormal red blood cells from forming, which may reduce the number of painful sickle cell crises and the need for blood transfusions. It is a type of antimetabolite.

Table 1. Record
IdentifierMLC-T-ONC-002587
FieldOncology and biomedicine
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-002587",
  "term": "Droxia",
  "field": "Oncology and biomedicine",
  "definition": "A drug that contains the active ingredient hydroxyurea and is used to treat certain patients with sickle cell anemia. It is also being studied in the treatment of other conditions and some types of cancer. Droxia may help keep abnormal red blood cells from forming, which may reduce the number of painful sickle cell crises and the need for blood transfusions. It is a type of antimetabolite.",
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/droxia/"
}

Record 6,250 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.